Stock Scorecard
Stock Summary for Biodesix Inc (BDSX) - $1.30 as of 11/20/2024 7:48:54 PM EST
Total Score
7 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BDSX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BDSX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BDSX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BDSX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BDSX (24 out of 90)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for BDSX
Financial Details for BDSX
Company Overview |
|
|---|---|
| Ticker | BDSX |
| Company Name | Biodesix Inc |
| Country | USA |
| Description | Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 1.30 |
| Price 4 Years Ago | 20.16 |
| Last Day Price Updated | 11/20/2024 7:48:54 PM EST |
| Last Day Volume | 599,619 |
| Average Daily Volume | 328,962 |
| 52-Week High | 2.21 |
| 52-Week Low | 1.11 |
| Last Price to 52 Week Low | 17.12% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 51.15 |
| Sector PE | 40.32 |
| 5-Year Average PE | -2.89 |
| Free Cash Flow Ratio | 5.91 |
| Industry Free Cash Flow Ratio | 10.25 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 3.40 |
| Total Cash Per Share | 0.22 |
| Book Value Per Share Most Recent Quarter | 0.19 |
| Price to Book Ratio | 6.48 |
| Industry Price to Book Ratio | 1.89 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 2.75 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.70 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 145,467,000 |
| Market Capitalization | 189,107,100 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 20.32% |
| Reported EPS 12 Trailing Months | -0.37 |
| Reported EPS Past Year | -0.29 |
| Reported EPS Prior Year | -0.65 |
| Net Income Twelve Trailing Months | -43,819,000 |
| Net Income Past Year | -52,146,000 |
| Net Income Prior Year | -65,447,000 |
| Quarterly Revenue Growth YOY | 34.50% |
| 5-Year Revenue Growth | 2.52% |
| Operating Margin Twelve Trailing Months | -0.47 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 31,406,000 |
| Total Cash Past Year | 26,284,000 |
| Total Cash Prior Year | 43,088,000 |
| Net Cash Position Most Recent Quarter | -8,634,000 |
| Net Cash Position Past Year | -13,794,000 |
| Long Term Debt Past Year | 40,078,000 |
| Long Term Debt Prior Year | 30,127,000 |
| Total Debt Most Recent Quarter | 40,040,000 |
| Equity to Debt Ratio Past Year | 0.10 |
| Equity to Debt Ratio Most Recent Quarter | 0.41 |
| Total Stockholder Equity Past Year | 4,580,000 |
| Total Stockholder Equity Prior Year | 20,606,000 |
| Total Stockholder Equity Most Recent Quarter | 27,857,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -62,211,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.43 |
| Free Cash Flow Past Year | -45,789,000 |
| Free Cash Flow Prior Year | -48,270,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.08 |
| MACD Signal | -0.07 |
| 20-Day Bollinger Lower Band | 1.28 |
| 20-Day Bollinger Middle Band | 1.65 |
| 20-Day Bollinger Upper Band | 2.02 |
| Beta | 1.21 |
| RSI | 30.99 |
| 50-Day SMA | 1.63 |
| 150-Day SMA | 1.76 |
| 200-Day SMA | 4.56 |
System |
|
| Modified | 11/20/2024 7:06:42 PM EST |